| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/07/2011 | US20110082107 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 04/07/2011 | US20110082106 Methods of activating nkt cells |
| 04/07/2011 | US20110082099 Methods and Compositions for the Treatment of Cystic Fibrosis and Related Illnesses |
| 04/07/2011 | US20110082076 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 04/07/2011 | US20110082075 Anti-viral fusion peptides |
| 04/07/2011 | US20110082074 Agent for preventing periodontal disease |
| 04/07/2011 | US20110082073 Modified Cpn10 and PRR signalling |
| 04/07/2011 | US20110082070 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 04/07/2011 | US20110081434 Extract of Coptidis Rhizoma and novel use thereof in treating respiratory disease |
| 04/07/2011 | US20110081411 Orally Administered Corticosteroid Compositions |
| 04/07/2011 | US20110081405 Zeolite Formulation And Use Thereof For The Prevention And Therapy Of Diseases Caused By Infections With Herpes Simplex Virus Type 1 And Type 2 |
| 04/07/2011 | US20110081384 Methods of wound care and treatment |
| 04/07/2011 | US20110081382 Treatment and prevention of tuberculosis |
| 04/07/2011 | US20110081381 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110081380 Stabilizing Excipient for Inactivated Whole Virus Vaccine |
| 04/07/2011 | US20110081379 Purification method and method of producing vaccine |
| 04/07/2011 | US20110081378 Composition comprising iscom particles and live micro-organisms |
| 04/07/2011 | US20110081377 Aerosolized genetic vaccines and methods of use |
| 04/07/2011 | US20110081376 Method for using inactivated japanese encephalitis virus particles as adjuvant |
| 04/07/2011 | US20110081375 Chimeric adenoviral vectors |
| 04/07/2011 | US20110081374 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 04/07/2011 | US20110081373 Attenuating mutations in the influenza a virus nep(=ns2) protein |
| 04/07/2011 | US20110081370 Methods and Compositions for Modulating Immune Tolerance |
| 04/07/2011 | US20110081368 Protein vaccines against poxviruses |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
| 04/07/2011 | US20110081364 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| 04/07/2011 | US20110081357 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 04/07/2011 | US20110081355 Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies |
| 04/07/2011 | US20110081348 Fungal signalling and metabolic enzymes |
| 04/07/2011 | US20110081347 Antibodies with Altered Binding to FcRn and Methods of Using Same |
| 04/07/2011 | US20110081341 Immunopotentiative composition |
| 04/07/2011 | US20110081336 Processing biomass |
| 04/07/2011 | US20110081335 Processing biomass |
| 04/07/2011 | US20110081319 Composition and use of phyto-percolate for treatment of disease |
| 04/07/2011 | US20110081314 Antiviral phosphinate compounds |
| 04/07/2011 | US20110081292 Methods Of Treating Viral Hepatitis |
| 04/07/2011 | US20110079528 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2011 | DE102005018642B4 Verwendung von Verbindungen zur Hemmung der Glyoxalasen Use of compounds to inhibit the glyoxalases |
| 04/07/2011 | CA2779506A1 Methods of improving vaccine immunogenicity |
| 04/07/2011 | CA2776534A1 Piscine reovirus diagnostic compositions |
| 04/07/2011 | CA2776386A1 Piscine reovirus immunogenic compositions |
| 04/07/2011 | CA2776366A1 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| 04/07/2011 | CA2776363A1 Virus inactivating sheet |
| 04/07/2011 | CA2776351A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
| 04/07/2011 | CA2776271A1 Anti-hsv antibody |
| 04/07/2011 | CA2776195A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | CA2775794A1 Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunization |
| 04/07/2011 | CA2775720A1 Peptides for inducing heterosubtypic influenza t cell responses |
| 04/07/2011 | CA2775670A1 Crosslinked hydrogels and related method of preparation |
| 04/07/2011 | CA2774754A1 Phosphoramidate derivatives of nucleosides |
| 04/06/2011 | EP2305796A1 Process for producing cytotoxic lymphocytes |
| 04/06/2011 | EP2305793A1 Process for producing cytotoxic lymphocytes |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305700A1 Therapeutic USPA1-derived peptides |
| 04/06/2011 | EP2305699A1 Stabilised mRNA with increased G/C content which is optimised for translation in its coded areas |
| 04/06/2011 | EP2305698A2 Macrocyclic inhibitors of Hepatitis C virus replication |
| 04/06/2011 | EP2305697A2 Macrocyclic inhibitors of Hepatitis C virus replication |
| 04/06/2011 | EP2305696A2 Macrocyclic inhibitors of Hepatitis C virus replication |
| 04/06/2011 | EP2305695A2 Macrocyclic inhibitors of Hepatitis C virus replication |
| 04/06/2011 | EP2305680A2 Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305643A1 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers |
| 04/06/2011 | EP2305637A2 Substituted tetracycline compounds |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305304A1 Immunopotentiating agent comprising ep1 agonist |
| 04/06/2011 | EP2305303A2 Immunization against Clostridium difficile disease |
| 04/06/2011 | EP2305298A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305297A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305296A1 Immunogenic composition for use in vaccination against staphylococcei |
| 04/06/2011 | EP2305295A1 Immunogenic composition for use in vaccination against staphylococcei |
| 04/06/2011 | EP2305294A1 Immunogenic composition for use in vaccination against staphylococcei |
| 04/06/2011 | EP2305293A2 Immunization against Clostridium difficile disease |
| 04/06/2011 | EP2305292A1 S/o type transdermal immunizing agent |
| 04/06/2011 | EP2305291A1 Use of proteasome inhibitors for the treatment of HIV infections |
| 04/06/2011 | EP2305287A1 Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
| 04/06/2011 | EP2305270A1 Anti-adhesive carbohydrates |
| 04/06/2011 | EP2305250A1 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 04/06/2011 | EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels |
| 04/06/2011 | EP2305243A1 Use of artemisinin and related compounds for treating diseases induced by human papilloma virus |
| 04/06/2011 | EP2305234A1 Pharmaceutical composition for treatment or prevention of hbv infection |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2304043A1 Hiv protease inhibitors and methods for using |
| 04/06/2011 | EP2303893A1 Tricyclic indole derivatives and methods of use thereof |
| 04/06/2011 | EP2303876A1 Diketo azolopiperidines and azolopiperazines as anti-hiv agents |
| 04/06/2011 | EP2303844A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 04/06/2011 | EP2303837A2 Novel compounds, use thereof as medicaments, and method for the preparation thereof |
| 04/06/2011 | EP2303329A1 Antifungal combination therapy |
| 04/06/2011 | EP2303318A2 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
| 04/06/2011 | EP2303317A2 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains |
| 04/06/2011 | EP2303312A2 Smallpox dna vaccine and the antigens therein that elicit an immune response |
| 04/06/2011 | EP2303307A2 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 04/06/2011 | EP2303296A2 Orally administerable vaccine for yersinia pestis |
| 04/06/2011 | EP2303295A1 Controlled activation of the reuterin-production machinery of lactobacillus reuteri |
| 04/06/2011 | EP2303294A1 Probiotics to improve gut microbiota |
| 04/06/2011 | EP2303271A1 Treatment of antibiotic-resistant bacteria infection |
| 04/06/2011 | EP2303265A2 Stable topical formulation comprising voriconazole |